The Dean Reveals the Greatest Advancement in the History of Pennystocking
June 22nd, 2009 at 9:30 am Posted by The DeanThe Dean just received his invitation for the Wide World of Stocks launch party, which signals the beginning of a wholly unprecedented moment in the world of penny stock marketing. Never before has a similar show aired to 95 million homes that markets a particular penny stock, and I believe the numbers will speak for themselves after the show airs on Sunday, June 28th.
The cameras will be rolling, and clips from the launch party will be available on WideWorldofStocks.com in the coming weeks. I have been working tirelessly the last 5 years to create a truly educational portal for Penny Stock trading here at CollegeStock, and once this show airs, The Dean will have the means to invest whatever it takes to create that community. Sign up to WideWorldofStocks.com right now to be kept up to date on show air times, channel listings, and the Greatest Advancement in the History of the PennyStocking.
As you can see by the invitation above, The Wide World of Stocks’ first sponsored company is Viral Genetics (VRAL), a biotechnology company that discovers and develops immune-based therapies for HIV and AIDS using its thymus nuclear protein compound. The company’s nuclear protein compound may have other potential applications for other infectious, autoimmune, and immunological deficiency diseases that the company intends to study in the future. Key players involved include scientists at Harvard Medical School, Bill Gates’ lead patent attorney and the 2008 Nobel Prize Winner in the field of Medicine.
I have bought 487,000 shares in the open market and on June 28th over 50 million viewers will have the opportunity to learn about VRAL and how you can profit from ‘Biotechnology Month’ at CollegeStock.com.
It’s biotechnology month for a very good reason, and I believe VRAL could be a 20-bagger if a healthy percentage of TV viewers invest in the long term vision of Viral Genetics.
Be sure to see:
WideWorldofStocks.com – Get the latest news this week about the site launch and show air dates.
The Dean’s List - Join The Dean’s List to become a CollegeStock Honors Student today.








Signed up for the Wide World of Stocks email list, I expect big things from you Mr. Dean — you haven’t let me down yet!!
VRAL looks ready to pop on Monday, looking to get in under $.08 in the early AM. Any current VRAL shareholders here?
VRAL has been working on their therapies for the last 6 years and is eventually getting the recognition it deserves.
I have been following this company for years and know the individuals involved and the commitment and dedication they have shown to this company is amazing !!!
I’m looking forward to the show and seeing Viral Genetics gain the
recognition it finally deserves. They have been working on HIV and
Cancer for so long and their advisory staff is extremely
knowledgeable, holding several patents and co-authoring lots of
research papers. Dr. Karen Newell particularly stands out for me
within the group.
I can’t wait for the news and truth about Viral Genetics to reach many
a new and eager audience over the next week !
Huge run up, but i can´t say where´s the top.
(I believe, we have already some big players in)
VRAL is one of the few biotechs in uncharted waters; meaning, it has gone mostly undiscovered by the finacial community. With all of the positive things the company has going (mentioned above), this stock is a strong buy and we will see a huge upside as the momentum builds. Truly an exciting story that investors will buy into. This stock could see $1.00 in the near future.